Accurate, balanced evidence-based information about medicines
Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDFNPS RADAR April 2007 NPS RADAR April 2007
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR April 2007 NPS RADAR>Full Issue>Health Professional Publication | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Ciprofloxacin ear drops (Ciloxan) for chronic suppurative otitis media in Aboriginal and Torres Strait Islander people NPS RADAR>Brief Item>Health Professional Publication | Ciprofloxacin ear drops (Ciloxan) were listed on the PBS to allow prescribing for chronic suppurative otitis media (CSOM) in Aboriginal and Torres Strait Islander people. |
| Sildenafil (Revatio) listed for pulmonary hypertension NPS RADAR>Brief Item>Health Professional Publication | Sildenafil (Revatio) was PBS listed as a Section 100 hospital Authority-required item for the treatment of primary pulmonary hypertension or pulmonary hypertension associated with connective tissue disease in patients categorised as WHO functional class III. |
| Trandolapril 4 mg with verapamil sustained-release 240 mg fixed-dose combination tablet (Tarka) to be listed on PBS NPS RADAR>Brief Item>Health Professional Publication | Trandolapril 4 mg with verapamil sustained release 240 mg fixed-dose combination tablet (Tarka) will be listed on the PBS for people already stabilised on antihypertensive treatment who wish to reduce the number of tablets they take each day. |
| Medicine Update: the new consumer version of NPS RADAR NPS RADAR>Brief Item>Health Professional Publication | Medicine Update, a new publication from NPS, will review newly listed PBS medicines for a consumer audience, with a quality use of medicines focus, and will be available on-line from the NPS website. |
| Alendronate (Alendro Once Weekly, Fosamax Once Weekly, Fosamax Plus) for osteoporosis in people at high risk of fracture NPS RADAR>Review>Health Professional Publication | Reviews extension of PBS listing for alendronate to include treatment of osteoporosis without fracture in older people with low bone mineral density scores. |
| Methylphenidate extended-release (Concerta) for attention deficit hyperactivity disorder (ADHD) NPS RADAR>Review>Health Professional Publication | Reviews use of extended-release methylphenidate, including comparison with immediate-release formulation and risk of cardiovascular adverse effects. |
| Additional content - Extended-release methylphenidate (Concerta) for attention deficit hyperactivity disorder NPS RADAR>Web Only Item>Health Professional Publication |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2007-04-01 00:00:00
The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of clinical circumstances of each patient.
RSS feed
